About phyton

This author has not yet filled in any details.
So far phyton has created 14 blog entries.

Phyton to meet with global pharmaceutical manufacturing leaders at DCAT

By |2018-03-19T01:38:45+00:00March 14th, 2018|

Phyton to meet with global pharmaceutical manufacturing leaders at DCAT We are pleased to announce our upcoming participation at Drug, Chemicals, and Associated Technologies (DCAT) conference in New York City from March 20-22, 2018. DCAT conference 2018 At DCAT, Phyton Biotech will be meeting with global [...]

Phyton Biotech to Present at High-Value Chemicals from Plants Network in Scotland

By |2018-01-30T17:00:04+00:00January 30th, 2018|

Phyton Biotech to Present at High-Value Chemicals from Plants Network in Scotland Phyton Biotech is pleased to announce that Dr. Gilbert Gorr, Chief Scientific Officer at Phyton Biotech, will be presenting at Plant Cell Cultures: Production of High-Value Chemicals, an upcoming biotech industry workshop for researchers [...]

Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin

By |2018-09-18T18:37:36+00:00November 29th, 2017|

Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin Bill & Melinda Gates Foundation Invests in R&D Pilot for Anti-Malarial Active Pharmaceutical Ingredients AHRENSBURG, Germany, November 29, 2017 – Phyton Biotech today announced that it has received a $400,000 grant from the Bill & [...]

Phyton Biotech showcased plant cell fermentation at CPhI Worldwide

By |2017-11-11T01:54:47+00:00November 11th, 2017|

Phyton Biotech showcased plant cell fermentation at CPhI Worldwide NOVEMBER 9, 2017 This October, Phyton Biotech attended CPhI Worldwide to exhibit its capabilities and the wide range of applications for the company’s proprietary Plant Cell Fermentation Technology (PCF®). CPhI Worldwide is the largest pharmaceutical industry trade [...]

Case Study: Green Chemistry

By |2017-10-17T15:58:39+00:00October 17th, 2017|

Case Study: Green Chemistry Phyton Biotech develops and applies sustainable “green technology” manufacturing solutions for phytochemicals through its award-winning and proprietary Plant Cell Fermentation (PCF®) process. The impact of this revolutionary technology is exemplified by Phyton’s environmentally responsible Paclitaxel manufacturing process. Summary of Problem: [...]

Case Study: Green Chemistry

By |2018-10-04T21:05:07+00:00October 7th, 2017|

Taxol® (manufactured by Bristol-Myers Squibb) is an important drug used to treat many types of solid tumor cancers and Kaposi’s sarcoma. It is on the World Health Organization’s List of Essential Medicines, the most needed medicines in a health care system.

Upcoming Conferences

By |2018-01-24T17:35:20+00:00October 6th, 2017|

Phyton Biotech will be attending the following conference and exhibition events. Drug, Chemical & Associated Technologies Association (DCAT) Week 2018 March 19-22, 2018 New York City, USA

Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin

By |2017-11-12T23:20:36+00:00August 22nd, 2016|

Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection with the manufacture of thapsigargin, an inhibitor derived from the Thapsia plant that is the active agent for the investigational [...]

Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)

By |2017-11-12T23:23:40+00:00July 13th, 2015|

Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)Production of Thapsigargins by Thapsia Cell Suspension Culture" Filed by Phyton Biotech SAN ANTONIO, TX--(Marketwired - Jul 13, 2015) - GenSpera, Inc. (OTCQB: GNSZ) today announced that its strategic partner Phyton Biotech, the pioneer [...]